Borbone, Eleonora (2009) EVALUATION OF HISTONE DEACETYLASE INHIBITOR EFFECTS ON THYROID CANCER. [Tesi di dottorato] (Unpublished)

[thumbnail of Borbone_Eleonora.pdf]
Preview
PDF
Borbone_Eleonora.pdf

Download (21MB) | Preview
Item Type: Tesi di dottorato
Resource language: English
Title: EVALUATION OF HISTONE DEACETYLASE INHIBITOR EFFECTS ON THYROID CANCER
Creators:
Creators
Email
Borbone, Eleonora
elly_norab@yahoo.it
Date: 31 March 2009
Number of Pages: 89
Institution: Università degli Studi di Napoli Federico II
Istituzioni (extra): CEINGE  Biotecnologie Avanzate
Department: CEINGE Biotecnologie avanzate
Scuola di dottorato: SEMM – European School of Molecular Medicine
Dottorato: PhD in Molecular Medicine (Molecular Oncology or Human Genetics)
Ciclo di dottorato: 20
Coordinatore del Corso di dottorato:
nome
email
Salvatore, Francesco
UNSPECIFIED
Tutor:
nome
email
Fusco, Alfredo
afusco@napoli.com
Simeone, Antonio
UNSPECIFIED
Gronemeyer, Hinrich
UNSPECIFIED
Date: 31 March 2009
Number of Pages: 89
Keywords: HDAC, thyroid, cancer
Settori scientifico-disciplinari del MIUR: Area 05 - Scienze biologiche > BIO/11 - Biologia molecolare
Area 06 - Scienze mediche > MED/06 - Oncologia medica
Additional information: Ciclo II/XX, Curriculum Molecular Oncology
Date Deposited: 16 Nov 2009 14:59
Last Modified: 14 Jan 2015 12:26
URI: http://www.fedoa.unina.it/id/eprint/3402
DOI: 10.6092/UNINA/FEDOA/3402

Collection description

Abstract Histone deacetylases (HDACs) play a crucial role in the proper regulation of cellular functions through their connection with chromatin and transcriptional regulation. Alterations in HDAC activity have been reported in several types of cancer encouraging development of HDAC inhibitors (HDACis) for cancer treatment. The antitumor activity of HDACi has been demonstrated, in clinical trials, in both solid and non solid neoplasias at doses well tolerated by patients. However, the molecular basis for their tumor selectivity is unknown. Anaplastic thyroid carcinoma (ATC) is one of the most aggressive malignancies, having a poor prognosis and being refractory to conventional chemo- and radiotherapy. To the aim to find an innovative therapy for the treatment of ATCs, we studied the effects of two potent HDACis, SAHA and MS-275, on rat thyroid cell lines transformed by the v-ras-Ki oncogene which is frequently mutated in ATCs. We show that: i) HDAC 1 and HDAC 2 are overexpressed in anaplastic thyroid carcinomas compared to normal thyroid; ii) SAHA and MS-275 induce apoptosis selectively in completely transformed rat thyroid cells; iii) TNF-related apoptosis-inducing ligand (TRAIL) is the main mediator of cell death induced by SAHA; iv) SAHA stabilize TRAIL protein by affecting its proteasome-mediated degradation.

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item